NCT05790356 (FeMiTRA) is a NA clinical trial of Fecal Microbial transplant in Arthritis, sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's.

What drugs are being tested in NCT05790356?

Interventions in NCT05790356: Fecal Microbial transplant, Placebo capsules.

What condition does NCT05790356 study?

NCT05790356 studies Arthritis, Arthritis, Rheumatoid, Fecal Microbiota Transplantation.

Is NCT05790356 still recruiting?

NCT05790356 is currently recruiting now. Last updated 21 August 2024.

Last reviewed 2024-08-21 · How we verify

NCT05790356: FeMiTRA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

Recruiting now NA Last updated 21 August 2024

What this trial tests

NA trial testing Fecal Microbial transplant in Arthritis in 30 participants. Currently enrolling.

Timeline

1 August 2023

Primary endpoint
1 August 2025

1 April 2026

Quick facts

Lead sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	1 August 2023
Primary completion	1 August 2025
Estimated completion	1 April 2026
Sites	1 location across Canada

Drugs / interventions tested

Fecal Microbial transplant — full drug profile →
Placebo capsules — full drug profile →

Conditions studied

Arthritis — all drugs for Arthritis →
Arthritis, Rheumatoid — all drugs for Arthritis, Rheumatoid →
Fecal Microbiota Transplantation — all drugs for Fecal Microbiota Transplantation →

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Who can join

18 and older, any sex, with Arthritis or Arthritis, Rheumatoid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial will investigate the effects of capsules containing stool from healthy donors, called fecal microbial transplant (FMT), in rheumatoid arthritis patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy.
Chasov V, Gilyazova E, Ganeeva I, Zmievskaya E, et al · · 2024 · cited 10× · PMID 39766360 · DOI 10.3390/biom14121653
Innovations in immunotherapy for autoimmune diseases: recent breakthroughs and future directions.
Alsayb MA. · · 2025 · cited 2× · PMID 41041324 · DOI 10.3389/fimmu.2025.1647066
The Oral-Gut-Immune-Nutrition Axis in Rheumatoid Arthritis: Molecular Mechanisms and Therapeutic Implications.
Reytor-González C, Román-Galeano NM, Aules-Curicama LS, Cevallos-Villacis CD, et al · · 2026 · PMID 41828603 · DOI 10.3390/ijms27052385

Verify or expand the search:

Other recruiting trials for Arthritis

Currently open trials in the same condition.

NCT05067998 — The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature · recruiting
NCT07284563 — Ultralow Dose PET Imaging for 18F-NaF Uptake · Phase 2 · recruiting
NCT06915012 — Impact of Biophoton Therapy on Chronic Severe Arthritis Pain · NA · recruiting
NCT06880653 — Dose Response of Exercise for Arthritis Management · NA · recruiting
NCT07106931 — Early STratification of Acute ARThritis · recruiting

Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials

Trials by the same sponsor.

NCT07588711 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Neuropathic Pain Following Spinal Cord Injury · NA · not yet recruiting
NCT07585292 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Musculoskeletal Pain in Cerebral Palsy · NA · not yet recruiting
NCT07510906 — Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer · NA · not yet recruiting
NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
NCT06035809 — Sensory Motor Arousal Regulation Treatment (SMART) Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05790356 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Last refreshed: 21 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05790356.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing